share_log

BioNTech | 6-K: Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union

BioNTech | 6-K: Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union

BioNTech | 6-K:輝瑞和BioNTech的Omicron JN.1適應型COVID-19疫苗在歐盟獲得CHMP積極評價
美股SEC公告 ·  06/28 16:10
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息